Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease

Background: We estimated the prevalence and incidence of 14 human papillomavirus (HPV) types (6/11/ 16/18/31/33/35/39/45/51/52/56/58/59) in cervicovaginal swabs, and the attribution of these HPV types in cervical intraepithelial neoplasia (CIN), and adenocarcinoma in situ (AIS), using predefined alg...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2014

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/23633

Acceso en línea:

https://doi.org/10.1158/1055-9965.EPI-14-0410
https://repository.urosario.edu.co/handle/10336/23633

Palabra clave:

Placebo
Wart virus vaccine
Wart virus vaccine
Adenocarcinoma
Adolescent
Adult
Algorithm
Alphapapillomavirus
Article
Controlled study
Double blind procedure
Drug efficacy
Drug safety
Female
Follow up
Genotype
Groups by age
High risk patient
Human
Human papillomavirus type 11
Human papillomavirus type 16
Human papillomavirus type 18
Human papillomavirus type 31
Human papillomavirus type 33
Human papillomavirus type 35
Human papillomavirus type 39
Human papillomavirus type 45
Human papillomavirus type 51
Human papillomavirus type 52
Human papillomavirus type 56
Human papillomavirus type 58
Human papillomavirus type 59
Human papillomavirus type 6
Human tissue
Incidence
Infection prevention
Major clinical study
Mixed infection
Nonhuman
Papanicolaou test
Papillomavirus infection
Persistent infection
Phase 3 clinical trial
Prevalence
Randomized controlled trial
Uterine cervix adenocarcinoma
Uterine cervix biopsy
Uterine cervix cancer
Uterine cervix carcinoma in situ
Uterine cervix cytology
Vaccination
Cervical intraepithelial neoplasia
Genetics
Genotype
Middle aged
Papillomaviridae
Papillomavirus infections
Risk factor
Uterine cervical neoplasms
Virology
Young adult
Adolescent
Adult
Cervical intraepithelial neoplasia
Double-blind method
Female
Genotype
Humans
Incidence
Middle aged
Papillomaviridae
Papillomavirus infections
Papillomavirus vaccines
Prevalence
Risk factors
Uterine cervical neoplasms
Young adult

Rights

License

Abierto (Texto Completo)